Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
2016 Standout
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
2013
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 Standout
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
2013
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Opportunities and challenges in the development of kinase inhibitor therapy for cancer
2003
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
2017
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Atelocollagen for protein and gene delivery
2003
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin’s Lymphoma
2016
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Hydrogels in Regenerative Medicine
2009 Standout
Expression of ROCK-1 in Human Pancreatic Cancer: Its Down-Regulation by Morpholino Oligo Antisense Can Reduce the Migration of Pancreatic Cancer Cells In Vitro
2002
Molecular monitoring of BCR–ABL as a guide to clinical management in chronic myeloid leukaemia
2005
Juvenile idiopathic arthritis
2007 Standout
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
2011
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
2017
Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT)
2008
Engineering mesenchymal stem cells for immunotherapy
2003
Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors
2011
Dynamics of chronic myeloid leukaemia
2005 Nature
Delivery technologies for cancer immunotherapy
2019 Standout
Antibody therapy of cancer
2012 Standout
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies
2013
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
2013
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism
2008
Hematopoietic Stem-Cell Transplantation
2006 Standout
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Diffuse large B-cell lymphoma—treatment approaches in the molecular era
2013
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
2005 Standout
Engineering thick tissues - the vascularisation problem
2007
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
2012
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
2017
Neutropenia in a Patient Treated With Ipilimumab (anti–CTLA-4 Antibody)
2009
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995)
2004
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass
2007
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Neutropenic enterocolitis in adults: systematic analysis of evidence quality
2005
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement
2021 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Diffuse large B-cell lymphoma
2013
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
2004
The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib
2010
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Lipids and Alzheimer’s Disease
2020
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's disease
1984
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
2004 Standout
Acute Myeloid Leukemia
2015 Standout
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]
1996
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
2018
Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl
2004
Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia in First or Subsequent Remission: Weighing Prognostic Markers Predicting Relapse and Risk Factors for Non-relapse Mortality
2008
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Multiple Sclerosis
2018 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Rapid Diagnosis of Cytomegaloviral Pneumonia by Tissue Immunofluorescence with a Murine Monoclonal Antibody
1985 StandoutNobel
Effects of glucagon on adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine
1970 StandoutNobel
Biodegradable polymers as biomaterials
2007 Standout
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
2012
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Outcomes of patients with relapsed/refractory diffuse large B‐cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era
2013
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2011
Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma
2012
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML
2006
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
Chimeric Antigen Receptor Therapy
2018 Standout
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
Biomaterials & scaffolds for tissue engineering
2011 Standout
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma
2008
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Transformed follicular non-Hodgkin lymphoma
2014
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Multiple Myeloma
2011 Standout
Pixantrone–Rituximab Versus Gemcitabine–Rituximab In Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
2016
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
2010
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML
2004
Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy
2015
New Insights into the Pathophysiology of Chronic Myeloid Leukemia and Imatinib Resistance
2006
Über den diuretischen und saluretischen Effekt von Glucagon beim Menschen
1963
Widespread presence of histologically occult cytomegalovirus
1984
Works of Dávid Ma being referenced
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
2010
Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice
2018
Platelet activation in acute pulmonary embolism
2007
A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation
2004
Profound thrombocytopenia related to G‐CSF
2006
The Influence of Induction Chemotherapy Dose and Dose Intensity on the Duration of Remission in Acute Myeloid Leukemia
1994
Quality of Conduct and Reporting of Meta-analyses of Surgical Interventions
2015
Equivalent Survival for Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia
2007
In Vitro Effects of Detergent Sclerosants on Coagulation, Platelets and Microparticles
2007
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase
2003
Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma
2006
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
2016
A pilot randomized trial comparing CD34‐selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis
2002
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
2015
A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid
2003
ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETION
1982
[On the effect of glucagon on the water-electrolyte balance].
1960
Synthetic oligonucleotides as therapeutics: The coming of age
2000
R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study.
2007
Evidence for transdifferentiation of human bone marrow-derived stem cells: recent progress and controversies
2003
Autopsy findings in bone marrow transplantation
1982